$12.48
0.393.23%
At Close: -
$12.48
00.00%
After Hours: 4:01 PM EDT
15 minutes delayed
Rigel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Rigel Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.06 | $-0.29 | 79.3 % |
Mar 2024 | 2024-05-07 | $-0.50 | $-0.30 | -66.7 % |
Dec 2023 | 2024-03-05 | $0 | $-0.30 | 100.0 % |
Sep 2023 | 2023-11-07 | $-0.30 | $-0.70 | 57.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $36.84M | $33.42M | 10.2 % |
Mar 2024 | 2024-05-07 | $29.53M | $31.28M | -5.58 % |
Dec 2023 | 2024-03-05 | $35.79M | $34.10M | 4.96 % |
Sep 2023 | 2023-11-07 | $28.13M | $27.20M | 3.43 % |
Rigel Pharmaceuticals (RIGL) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.06, which beat the estimate of $-0.29.
The Actual Revenue was $36.8M, which beat the estimate of $33.4M.
Browse earnings estimates, EPS, and revenue on all stocks.